케이바이오랩스: directors' dealings · South Korea · DART (FSS)

Explore the full directors' dealings record of 케이바이오랩스, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €27.8bn. The latest transaction was reported on 16 March 2026 — Other. Among the most active insiders: 케이바이오랩스. Every trade is openly available.